UPDATE 1-Amgen drug meets goal for those with high genetic cholesterol
March 17, 2014 at 11:18 AM EDT
March 17 (Reuters) - Amgen Inc said on Monday its experimental new type of cholesterol fighter met the primary goal of a late-stage trial by significantly cutting "bad" LDL cholesterol among patients with a genetic tendency towards very high levels of the artery clogging fat.